Do analysts recommend LUCY or BMRA?

Biomerica has a consensus target price of $9.00, indicating a potential upside of 320.56%. Given Biomerica's higher possible upside, analysts plainly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to LUCY or BMRA?

In the previous week, Innovative Eyewear had 9 more articles in the media than Biomerica. MarketBeat recorded 17 mentions for Innovative Eyewear and 8 mentions for Biomerica. Biomerica's average media sentiment score of 1.22 beat Innovative Eyewear's score of -0.42 indicating that Biomerica is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innovative Eyewear 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Biomerica 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, BMRA or NXGL?

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $5.31M 1.25 -$4.97M -$0.89 N/A NexGel $12.07M 0.28 -$3M -$0.71 N/A

Is BMRA or NXGL more profitable?

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -96.49%. Biomerica's return on equity of -98.14% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets Biomerica -96.49% -98.14% -70.42% NexGel -51.26% -121.18% -41.15%

Does the media prefer BMRA or NXGL?

In the previous week, Biomerica had 4 more articles in the media than NexGel. MarketBeat recorded 8 mentions for Biomerica and 4 mentions for NexGel. Biomerica's average media sentiment score of 1.22 beat NexGel's score of -0.28 indicating that Biomerica is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biomerica 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NexGel 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BMRA or CUPR?

Biomerica presently has a consensus price target of $9.00, indicating a potential upside of 320.56%. Given Biomerica's higher possible upside, equities research analysts clearly believe Biomerica is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, BMRA or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $5.31M 1.25 -$4.97M -$0.89 N/A Cuprina Holdings (Cayman) $40K 69.23 -$3.63M N/A N/A

Do analysts prefer BMRA or LUCYW?

Biomerica presently has a consensus target price of $9.00, indicating a potential upside of 320.56%. Given Biomerica's stronger consensus rating and higher probable upside, research analysts clearly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, BMRA or LUCYW?

Innovative Eyewear has lower revenue, but higher earnings than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $5.31M 1.25 -$4.97M -$0.89 N/A Innovative Eyewear $3.41M N/A N/A N/A N/A

Does the media prefer BMRA or LUCYW?

In the previous week, Biomerica had 6 more articles in the media than Innovative Eyewear. MarketBeat recorded 8 mentions for Biomerica and 2 mentions for Innovative Eyewear. Biomerica's average media sentiment score of 1.22 beat Innovative Eyewear's score of 1.06 indicating that Biomerica is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biomerica 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Innovative Eyewear 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NXGLW or BMRA?

Biomerica has a consensus price target of $9.00, suggesting a potential upside of 320.56%. Given Biomerica's stronger consensus rating and higher possible upside, analysts plainly believe Biomerica is more favorable than NEXGEL. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, NXGLW or BMRA?

NEXGEL has higher revenue and earnings than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NEXGEL $12.07M N/A N/A N/A N/A Biomerica $5.31M 1.25 -$4.97M -$0.89 N/A

Is NXGLW or BMRA more profitable?

NEXGEL has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. NEXGEL's return on equity of 0.00% beat Biomerica's return on equity. Company Net Margins Return on Equity Return on Assets NEXGEL N/A N/A N/A Biomerica -96.49% -98.14% -70.42%

Biomerica (BMRA) Competitors

$2.14 0.00 (0.00%)

Closing price 08/28/2026 04:00 PM Eastern

Extended Trading

$2.10 -0.04 (-2.10%)

As of 04:28 AM Eastern

Compare

BMRA vs. LUCY, NXGL, CUPR, LUCYW, and NXGLW

Should you buy Biomerica stock or one of its competitors? Biomerica's main competitors and comparable companies include Innovative Eyewear (LUCY), NexGel (NXGL), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCYW), and NEXGEL (NXGLW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Biomerica compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCY) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 1.7% of Innovative Eyewear shares are held by insiders. Comparatively, 18.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Biomerica has a consensus target price of $9.00, indicating a potential upside of 320.56%. Given Biomerica's higher possible upside, analysts plainly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Innovative Eyewear had 9 more articles in the media than Biomerica. MarketBeat recorded 17 mentions for Innovative Eyewear and 8 mentions for Biomerica. Biomerica's average media sentiment score of 1.22 beat Innovative Eyewear's score of -0.42 indicating that Biomerica is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innovative Eyewear	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Biomerica	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Biomerica has higher revenue and earnings than Innovative Eyewear. Biomerica is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$3.41M	2.40	-$7.59M	-$1.29	N/A
Biomerica	$5.31M	1.25	-$4.97M	-$0.89	N/A

Innovative Eyewear has a beta of 2.72, indicating that its share price is 172% more volatile than the broader market. Comparatively, Biomerica has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

Biomerica has a net margin of -96.49% compared to Innovative Eyewear's net margin of -225.26%. Innovative Eyewear's return on equity of -88.90% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	-225.26%	-88.90%	-80.34%
Biomerica	-96.49%	-98.14%	-70.42%

Summary

Biomerica beats Innovative Eyewear on 9 of the 15 factors compared between the two stocks.

How does Biomerica compare to NexGel?

Biomerica (NASDAQ:BMRA) and NexGel (NASDAQ:NXGL) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -96.49%. Biomerica's return on equity of -98.14% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-96.49%	-98.14%	-70.42%
NexGel	-51.26%	-121.18%	-41.15%

22.3% of Biomerica shares are owned by institutional investors. Comparatively, 2.2% of NexGel shares are owned by institutional investors. 18.0% of Biomerica shares are owned by company insiders. Comparatively, 23.4% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Biomerica has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, NexGel has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Biomerica presently has a consensus target price of $9.00, indicating a potential upside of 320.56%. NexGel has a consensus target price of $2.00, indicating a potential upside of 468.18%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than Biomerica.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$5.31M	1.25	-$4.97M	-$0.89	N/A
NexGel	$12.07M	0.28	-$3M	-$0.71	N/A

In the previous week, Biomerica had 4 more articles in the media than NexGel. MarketBeat recorded 8 mentions for Biomerica and 4 mentions for NexGel. Biomerica's average media sentiment score of 1.22 beat NexGel's score of -0.28 indicating that Biomerica is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biomerica	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NexGel	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

NexGel beats Biomerica on 10 of the 15 factors compared between the two stocks.

How does Biomerica compare to Cuprina Holdings (Cayman)?

Biomerica (NASDAQ:BMRA) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$5.31M	1.25	-$4.97M	-$0.89	N/A
Cuprina Holdings (Cayman)	$40K	69.23	-$3.63M	N/A	N/A

Biomerica has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.35, indicating that its stock price is 135% less volatile than the broader market.

In the previous week, Biomerica had 6 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 8 mentions for Biomerica and 2 mentions for Cuprina Holdings (Cayman). Cuprina Holdings (Cayman)'s average media sentiment score of 1.43 beat Biomerica's score of 1.22 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Overall Sentiment
Biomerica	Positive
Cuprina Holdings (Cayman)	Positive

Biomerica presently has a consensus price target of $9.00, indicating a potential upside of 320.56%. Given Biomerica's higher possible upside, equities research analysts clearly believe Biomerica is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-96.49%	-98.14%	-70.42%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

22.3% of Biomerica shares are held by institutional investors. 18.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Biomerica and Cuprina Holdings (Cayman) tied by winning 6 of the 12 factors compared between the two stocks.

How does Biomerica compare to Innovative Eyewear?

Biomerica (NASDAQ:BMRA) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, Biomerica had 6 more articles in the media than Innovative Eyewear. MarketBeat recorded 8 mentions for Biomerica and 2 mentions for Innovative Eyewear. Biomerica's average media sentiment score of 1.22 beat Innovative Eyewear's score of 1.06 indicating that Biomerica is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biomerica	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innovative Eyewear	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Innovative Eyewear has lower revenue, but higher earnings than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$5.31M	1.25	-$4.97M	-$0.89	N/A
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

22.3% of Biomerica shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Innovative Eyewear has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. Innovative Eyewear's return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-96.49%	-98.14%	-70.42%
Innovative Eyewear	N/A	N/A	N/A

Biomerica presently has a consensus target price of $9.00, indicating a potential upside of 320.56%. Given Biomerica's stronger consensus rating and higher probable upside, research analysts clearly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Biomerica beats Innovative Eyewear on 7 of the 10 factors compared between the two stocks.

How does Biomerica compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and Biomerica (NASDAQ:BMRA) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

NEXGEL has a net margin of 0.00% compared to Biomerica's net margin of -96.49%. NEXGEL's return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NEXGEL	N/A	N/A	N/A
Biomerica	-96.49%	-98.14%	-70.42%

In the previous week, Biomerica had 6 more articles in the media than NEXGEL. MarketBeat recorded 8 mentions for Biomerica and 2 mentions for NEXGEL. Biomerica's average media sentiment score of 1.22 beat NEXGEL's score of 0.44 indicating that Biomerica is being referred to more favorably in the news media.

Company	Overall Sentiment
NEXGEL	Neutral
Biomerica	Positive

NEXGEL has higher revenue and earnings than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NEXGEL	$12.07M	N/A	N/A	N/A	N/A
Biomerica	$5.31M	1.25	-$4.97M	-$0.89	N/A

Biomerica has a consensus price target of $9.00, suggesting a potential upside of 320.56%. Given Biomerica's stronger consensus rating and higher possible upside, analysts plainly believe Biomerica is more favorable than NEXGEL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NEXGEL	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

22.3% of Biomerica shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Biomerica beats NEXGEL on 6 of the 10 factors compared between the two stocks.

Get Biomerica News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMRA vs. The Competition

Export

Metric	Biomerica	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$6.61M	$5.78B	$7.18B	$12.89B
Dividend Yield	N/A	1.75%	2.54%	11.27%
P/E Ratio	-2.40	25.92	273.17	25.45
Price / Sales	1.25	78.92	638.21	103.75
Price / Cash	N/A	33.69	28.74	36.03
Price / Book	1.33	6.18	11.08	6.36
Net Income	-$4.97M	$149.94M	$3.48B	$349.79M
7 Day Performance	27.38%	-0.22%	0.38%	-0.40%
1 Month Performance	43.62%	6.39%	7.89%	4.24%
1 Year Performance	-31.63%	6.29%	24.71%	15.13%

Biomerica Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMRA Biomerica	3.5041 of 5 stars	$2.14 flat	$9.00 +320.6%	-31.6%	$6.61M	$5.31M	N/A	60	Positive News
LUCY Innovative Eyewear	1.0093 of 5 stars	$0.70 -1.4%	N/A	-50.8%	$4.52M	$2.98M	N/A	9	Gap Down
NXGL NexGel	2.1488 of 5 stars	$0.38 -1.2%	$2.00 +426.3%	-85.6%	$3.51M	$11.42M	N/A	10	Short Interest Increase Gap Down
CUPR Cuprina Holdings (Cayman)	1.0379 of 5 stars	$2.86 -3.9%	N/A	N/A	$2.63M	$40K	N/A	14	Short Interest Decrease Gap Down
LUCYW Innovative Eyewear	N/A	$0.03 -3.3%	N/A	-58.5%	$0.00	$2.98M	N/A	9

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BMRA) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biomerica (BMRA) Competitors

BMRA vs. LUCY, NXGL, CUPR, LUCYW, and NXGLW

How does Biomerica compare to Innovative Eyewear?

Summary

How does Biomerica compare to NexGel?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Summary

How does Biomerica compare to Innovative Eyewear?

Summary

How does Biomerica compare to NEXGEL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biomerica (BMRA) Competitors

BMRA vs. LUCY, NXGL, CUPR, LUCYW, and NXGLW

How does Biomerica compare to Innovative Eyewear?

Do insiders and institutionals believe in LUCY or BMRA?

Do analysts recommend LUCY or BMRA?

Does the media refer more to LUCY or BMRA?

Which has stronger valuation and earnings, LUCY or BMRA?

Which has more volatility & risk, LUCY or BMRA?

Is LUCY or BMRA more profitable?

Summary

How does Biomerica compare to NexGel?

Is BMRA or NXGL more profitable?

Do institutionals and insiders have more ownership in BMRA or NXGL?

Which has more risk and volatility, BMRA or NXGL?

Do analysts rate BMRA or NXGL?

Which has preferable earnings & valuation, BMRA or NXGL?

Does the media prefer BMRA or NXGL?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Which has stronger earnings and valuation, BMRA or CUPR?

Which has more volatility & risk, BMRA or CUPR?

Does the media prefer BMRA or CUPR?

Do analysts recommend BMRA or CUPR?

Is BMRA or CUPR more profitable?

Do institutionals & insiders believe in BMRA or CUPR?

Summary

How does Biomerica compare to Innovative Eyewear?

Does the media prefer BMRA or LUCYW?

Which has better earnings & valuation, BMRA or LUCYW?

Do insiders & institutionals believe in BMRA or LUCYW?

Is BMRA or LUCYW more profitable?

Do analysts prefer BMRA or LUCYW?

Summary

How does Biomerica compare to NEXGEL?

Is NXGLW or BMRA more profitable?

Does the media prefer NXGLW or BMRA?

Which has stronger valuation & earnings, NXGLW or BMRA?

Do analysts prefer NXGLW or BMRA?

Do insiders and institutionals have more ownership in NXGLW or BMRA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools